HPLC/APCI -MS Determination of Telmisartan in Human Plasma

Hui Zhang
2004-01-01
Abstract:Objective: To develop an HPLC/MS method for the determination telmisartan in human plasma. Methods :LC:Use Agilent zorbax C18column(100 mm ×2. 1 mm,3 μm) ;The mobile phase consisting of methanol -water (70:30) ,a flow rate of 0. 2 mL · min-1,injection volume 20 μL. MS;Use atmospheric pressure chemical ioniza-tion(APCI) ,and selected ion mass spectral ( m/z) 513 (telmisartan) and 434 (internal standard) to quantify. The plasma samples were extracted with solid phase extraction. Results;The linear range of telmisartan was 1. 0 -500 μg · L-1 and the limit of detection was 1.0 μg · L-1 (S/N≥5). The recoveries of telmisartan were 99.3% -106. 5%. RSD of intra - day and inter - day were less than 10. 4% and 14. 0% , respectively. Conclusion: The method appears to be appropriate for the therapeutic monitoring of patients.
What problem does this paper attempt to address?